Charity awards £900,000 to vital breast cancer research

A £900,000 grant to allow an oncologist to establish a laboratory to undertake vital research into HER2-positive breast cancer has been awarded by charity Breakthrough Breast Cancer.

Dr Anthony Kong, who helps treat breast cancer patients within the Oxford Radcliffe NHS Trust, is the first clinician scientist to be funded via the charity’s clinical researcher programme.

HER2-positive breast cancer accounts for around 1 in 5 of the 46,000 breast cancers diagnosed in the UK each year.

Herceptin is a key treatment for this type of the disease but not all patients benefit from this drug.

Although doctors can confirm that a cancer is HER2-positive using immunohistochemistry or a technique called FISH, there is currently no reliable test to predict whether Herceptin will be effective for every patient.

neil.durham@haymarket.com

Breakthrough Breast Cancer

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Revalidation and ongoing fitness to practise cases will continue despite huge pressure...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Supporting men and children experiencing domestic violence through general practice

Supporting men and children experiencing domestic violence through general practice

IRIS is an evidence-based programme designed to reach female survivors of domestic...

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Loss of taste and smell and neurological aspects of 'long COVID' infection will be...

COVID-19 vaccine stocks must not be diverted to large sites ahead of local GPs, warns BMA

COVID-19 vaccine stocks must not be diverted to large sites ahead of local GPs, warns BMA

The government must ‘ramp up’ COVID vaccine supplies to general practice and avoid...

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led vaccination sites have delivered nearly three quarters of COVID-19 vaccine...